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Mice
All animal studies were carried out with permission, and in accordance with, animal care guidelines from the Institutional Animal
Care Use Committee (IACUC) at Case Western Reserve University and at collaborating facilities. Wild-type male mice on
C57BL6/J background (Jackson Laboratory) were bred in our facility and used for circadian studies. Mice were housed under
strict light–dark conditions (lights on at 6:00 and lights off at 18:00) and had free access to standard chow and water, and were
minimally disturbed for 4–6 weeks before the final experiment. Generation of systemic Klf15-null mice was as described
previously18. Klf15-null mice have been backcrossed into the C57BL6/J background for over ten generations18 and the BMAL1
mice were bred as previously described19. For Klf15-Tg mice, Flag–KLF15 was cloned downstream of an attenuated ˞-myosin
heavy-chain promoter as previously described20. This construct was injected into FVB (friend leukemia virus B mouse strain)
oocytes, and after germline transmission the mice were examined for expression of the transgene. Wild-type (non-Tg) littermates
served as controls. For light–dark experiments, mice were killed with CO  inhalation or isoflurane every 4h for 24h. For
constant dark experiments, mice were placed in complete darkness for 36h (starting at the end of light phase at ZT12) and
hearts were collected every 4h over a 24-h period.
RNA isolation and RT–PCR analysis:
After euthanasia, hearts were collected, washed in cold phosphate buffered saline, the atria removed and the ventricles
dissected to the apical and basal regions, and flash frozen in liquid nitrogen. RNA was isolated from the apical regions of frozen
heart samples by homogenization in Trizol reagent (Invitrogen) by following the manufacturer’s instructions (Invitrogen). RNA was
reverse transcribed after DNase treatment (New England Biolabs). RT–PCR was performed using locked nucleic acid (LNA)-
based TaqMan approach with primers and probes designed, and their efficiency tested, at the Universal Probe Library (Roche),
DQGZLWKȕDFWLQXVHGDVWKHQRUPDOL]LQJJHQH
Cell-culture studies
Neonatal rat ventricular myocytes were isolated from 1–2-day-old rat pups and grown under standard conditions18. Adenoviral
overexpression was performed for 24h and myocytes were then collected for mRNA and protein analysis. For synchronization,
the myocytes were starved in media containing insulin, transferrin and selenium (ITS supplement, Sigma-Aldrich) for 48h. After
this, the myocytes were synchronized with 50% horse serum for 30min, washed twice with no-serum media and replenished
with ITS-containing media. The mouse Klf15 promoter (approximately 5kb) was cloned into PGL3-basic (Promega). The rat
KChIP2 luciferase was a gift from P. H. Backx. Mutant constructs of rat KChIP2 luciferase were generated by PCR-based TOPO
cloning (Invitrogen), and site-directed mutagenesis was performed using Quikchange II mutagenesis kit (Agilent Technologies)
and confirmed by sequencing. Klf15 and KChIP2 luciferase studies were conducted in NIH3T3 cells, and luciferase activity was
normalized to protein concentration.
Western immunoblot analysis
For detecting Flag–KLF15, nuclear lysates were prepared using the NE-PER kit following manufacturer’s instructions (Thermo
Scientific) and probed with anti-Flag antibody (Sigma). For KChIP2 analysis, whole-cell lysates were prepared by homogenizing
the basal regions of the hearts in buffer containing Tris-HCl (50mM, pH7.4), NaCl (150mM), NP-40 (1%), sodium
deoxycholate (0.25%), EDTA (1mM), and supplemented with protease and phosphatase inhibitors (Roche). The blots were
probed with a mouse monoclonal antibody against KChIP2 (NIH Neuromab), normalized to tubulin (Sigma-Aldrich) and
quantified using Quantity One software (Bio-Rad).
ChIP
ChIP was performed with hearts as previously described21, 22. In brief, hearts were fixed with fresh 1.11% formaldehyde for 10
min, and then by chromatin preparation and sonication (Diagenode). The sonicated chromatin was immunoprecipitated using
BMAL1 or Flag antibody bound to Dynabeads (Invitrogen). The relative abundance was normalized to abundance of 28S
between the input and immunoprecipitated samples as previously described21. Primers that were used for BMAL1 ChIP on the
Klf15SURPRWHUZHUHIRUZDUGƍ*&&7*$*&$7&&7&&&&$7&$ƍUHYHUVHƍ****&&$&&7&7&7**$&77ƍDQGSUREH
ƍ)$0&&&*&&&$*7*$&&$7*7&7*&&7*7ƍ%+41RQWDUJHWSULPHUVZHUHIRUZDUGƍ*&&$$77&$&$777&$$&&$ƍ
UHYHUVHƍ*$&$&$$**&$777&$$ƍDQGSUREHƍ)$07*&$$$***&7**$&$7***ƍ%+43ULPHUVWKDWZHUHXVHGIRU
ChIP of Flag–KLF15 on the KChIP2SURPRWHUZHUHIRUZDUGƍ*&7&&*&7&7&$&77*&7ƍDQGUHYHUVHƍ
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Telemetry ECG and interval analysis
Mice were implanted with telemetry devices (ETA F20, Data Sciences International) and allowed to recover for at least 2 weeks.
ECGs were recorded from conscious mice continuously in their native environment and digital data (PhysioTel, Data Sciences
International) were stored for future analysis. Owing to rapid changes in the mouse heart rates, a weighted heart-rate approach
was used to assess rhythmic changes in QT interval, and measurements were made every 2h over a 24-h period. First, the
average heart rate was calculated for each hour by digital tracking of the ECG RR intervals (time interval between two
consecutive R waves) using the Dataquest analysis software (Data Sciences International). Then, during the first instance within
each hour when the average heart rate was present, the QT interval was measured using electronic calipers from two
consecutive beats. The QT interval was corrected for heart rate using a previously validated formula for conscious mice
QT/(RR/100)1/2 (ref. 23). A Cosinor model was applied to assess the 24-h rhythm in QT using a sinusoidal regression function
and raw data presented in four hourly blocks for visualization purposes.
Electrophysiological studies in myocytes
Murine ventricular myocytes were isolated using a standard enzymatic dispersion technique following overnight fast as previously
described24. Myocytes were re-suspended in media 199, allowed to recover and recordings were conducted within several hours
on the same day. The conventional whole-cell mode was used to record action potentials and I . In brief, myocytes were bathed
in a chamber that was continuously perfused with Tyrode’s solution of the following composition (in mmollí): NaCl, 137; KCl,
5.4; CaCl , 2.0; MgSO , 1.0; glucose, 10; and HEPES, 10 (pH7.35). Patch pipettes (0.9–1.5 M˖) were filled with electrode
solution composed of (in mmollí): aspartic acid, 120; KCl, 20; NaCl, 10; MgCl , 2; and HEPES, 5 (pH7.3). Action potentials
were elicited in current-clamp mode by injection of a square pulse of current of 5ms duration and 1.5–2 times the threshold
amplitude. APD was measured at 90% repolarization. To measure I , cells were placed in Tyrode’s solution (as described
earlier) containing 1˩M nisoldipine to block calcium current and calcium-activated chloride current, and tetrodotoxin (100 ˩mol
lí) to block sodium current. Cells were brought from a holding potential of –70 mV to –25 mV for 25ms. To isolate the fast,
transient component of the outward currents, I , the decay phase of outward potassium currents was fit by the exponential
functions of the form:
where Ĳ  is the time constant of decay of the fast, transient component of outward potassium currents; A  is the amplitude
coefficient of I Ĳ is the time constant of decay of the slow, transient component of the outward currents; A is the
amplitude of I ; and A is the amplitude coefficient of the non-inactivating steady-state outward potassium current I
Consistent with previous studies 25, the time constant of decay of the fast, transient component I  was 46±5ms. The
measured current amplitudes were normalized to cell capacitance and converted into current densities. All experiments were
conducted at 36°C. Cell capacitance and series resistance were compensated electronically at ~80%. Command and data
acquisition were operated with an Axopatch 200B patch-clamp amplifier controlled by a personal computer using a Digidata
1200 acquisition board driven by pCLAMP 7.0 software (Axon Instruments).
Programmed electrical stimulation
Intracardiac programmed electrical stimulation was performed as previously described26. In brief, mice were anaesthetized using
1.5% isoflurane in 95% O  after an overnight fast. ECG channels were amplified (0.1mVcmí) and filtered between 0.05 and
400 Hz. A computer-based data acquisition system (Emka Technologies) was used to record a 3-lead body surface ECG, and
up to four intracardiac bipolar electrograms. Bipolar right atrial pacing and right ventricular pacing were performed using 2-ms
current pulses delivered by an external stimulator (STG-3008, MultiChannel Systems; Reutlingen). Standard clinical
electrophysiologic pacing protocols were used to determine all basic electrophysiologic parameters. Overdrive pacing, single,
double and triple extrastimuli, as well as ventricular burst pacing, were delivered to determine the inducibility of ventricular
arrhythmias, which was tested twice.
Statistical analysis
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A cosinor model was adopted to determine whether there is a substantial 24-h rhythm in each physiological and molecular
variable of interest. By pooling data points of all mice, the model fits data to a fundamental sinusoidal function27. To determine
the coefficients (amplitude and phase) of the sinusoidal function and to see whether there were significant relationships, a mixed
model analysis of variance was performed using standard least-square regression and the restricted maximum likelihood method
(JMP 8.0, SAS Institute) as previously described28. Data are presented as mean ± s.e.m., the Student’s t-test was used for
assessing the difference between individual groups and P0.05 was considered statistically significant.
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